Advances in the management of spinal cord injury

Journal of the American Academy of Orthopaedic Surgeons

Volumn 18, Issue 4, 2010, Pages 210-222

  Gupta, Ranjan ^a   Bathen, Mary E ^b   Smith, Jeremy S ^a   Levi, Allan D ^a,c   Bhatia, Nitin N ^a   Steward, Oswald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951211577     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201004000-00004     Document Type: Review

References (73)

1. National Spinal Cord Injury Statistical Center: Spinal Cord Injury Facts and Figures at a Glance. National Spinal Cord Injury Statistical Center, Birmingham, Alabama, April 2009. Available at: https://www.nscisc.uab.edu/ public-content/facts-figures-2009.aspx. Accessed January 20, 2010.
2. Prusmack C, Rochman AS, Levi AD: The effect of age on survival following traumatic spinal cord injury. Topics in Spinal Cord Injury Rehabilitation 2006; 12: 49-57.
3. Hugenholtz H, Cass DE, Dvorak MF, et al: High-dose methylprednisolone for acute closed spinal cord injury: Only a treatment option. Can J Neurol Sci 2002; 29: 227-235.
4. Bracken MB, Holford TR: Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 1993; 79: 500507.
5. Silver J, Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-156.
6. Bareyre FM, Schwab ME: Inflammation, degeneration and regeneration in the injured spinal cord: Insights from DNA microarrays. Trends Neurosci 2003; 26: 555-563.
7. Rasouli A, Bhatia N, Dinh P, Cahill K, Suryadevara S, Gupta R: Resection of glial scar following spinal cord injury. J Orthop Res 2009; 27: 931-936.
8. Chesnut RM, Marshall LF, Klauber MR, et al: The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34: 216-222.
9. Levi L, Wolf A, Bekberg H: Hemodynamic parameters in patients with acute cervical cord trauma: Description, intervention, and prediction of outcome. Neurosurgery 1993; 33: 1007-1017.
10. Fehlings MG, Baptiste DC: Current status of clinical trials for acute spinal cord injury. Injury 2005; 36(suppl 2):B113-B122.
11. Bracken MB, Collins WF, Freeman DF, et al: Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984; 251: 45-52.
12. Bracken MB, Shepard MJ, Collins WF, et al: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
13. Bracken MB, Shepard MJ, Holford TR, et al: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277: 1597-1604.
14. Geisler FH, Dorsey FC, Coleman WP: Recovery of motor function after spinalcord injury: A randomized, placebocontrolled trial with GM-I ganglioside. N Engl J Med 1991; 324: 1829-1838.
15. Pitts LH, Ross A, Chase GA, Faden AI: Treatment with thyrotropin- releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 1995; 12: 235-243.
16. Otani K, Abe H, Kadoya S, et al: Beneficial effects of methylprednisolone sodium succinate in the treatment of acute spinal cord injury [Japanese]. Sekitsui Sekizui 1994; 7: 633-647.
17. Geisler FH, Coleman WP, Grieco G, Poonian D, Sygen Study Group: The Sygen multicenter acute spinal cord injury study. Spine (Phila Pa 1976) 2001; 26(24 suppl): S87-S98.
18. Petitjean ME, Pointillart V, Dixmerias F, et al: Medical treatment of spinal cord injury in the acute stage [French]. Ann Fr Anesth Reanim 1998; 17: 114-122.
19. Pointillart V, Petitjean ME, Wiart L, et al: Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord 2000; 38: 71-76.
20. Tadié M, D'Arbigny P, Mathé JF, et al: Early care and treatment with a neuroprotective drug, gacyclidine, in patients with acute spinal cord injury. Rachis 2003; 15: 363-376.
21. Fehlings MG, Perrin RG: The timing of surgical intervention in the treatment of spinal cord injury: A systematic review of recent clinical evidence. Spine (Phila Pa 1976) 2006; 31(11 suppl): S28-S35.
22. Dietrich WD III: Therapeutic hypothermia for spinal cord injury. Crit Care Med 2009; 37(7 suppl): S238-S242.
23. Kwon BK, Mann C, Sohn HM, et al: Hypothermia for spinal cord injury. Spine J 2008; 8: 859-874.
24. Yu CG, Jimenez O, Marcillo AE, et al: Beneficial effects of modest systemic hypothermia on locomotor function and histopathological damage following contusion-induced spinal cord injury in rats. J Neurosurg 2000; 93(1 suppl): 85-93.
25. Levi AD, Green BA, Wang MY, et al: Clinical application of modest hypothermia after spinal cord injury. J Neurotrauma 2009; 26: 407-415.
26. Aito S, D'Andrea M, Werhagen L, et al: Neurological and functional outcome in traumatic central cord syndrome. Spinal Cord 2007; 45: 292-297.
27. McKinley W, Meade MA, Kirshblum S, Barnard B: Outcomes of early surgical management versus late or no surgical intervention after acute spinal cord injury. Arch Phys Med Rehabil 2004; 85: 1818-1825.
28. Botel U, Gläser E, Niedeggen A: The surgical treatment of acute spinal paralysed patients. Spinal Cord 1997; 35: 420-428.
29. Marshall LF, Knowlton S, Garfin SR, et al: Deterioration following spinal cord injury: A multicenter study. J Neurosurg 1987; 66: 400-404.
30. Pollard ME, Apple DF: Factors associated with improved neurologic outcomes in patients with incomplete tetraplegia. Spine 2005; 28: 33-39.
31. Vaccaro AR, Daugherty RJ, Sheehan TP, et al: Neurologic outcome of early versus late surgery for cervical spinal cord injury. Spine (Phila Pa 1976) 1997; 22: 2609-2613.
32. La Rosa G, Conti A, Cardali S, Cacciola F, Tomasello F: Does early decompression improve neurological outcome of spinal cord injured patients? Appraisal of the literature using a meta-analytical approach. Spinal Cord 2004; 42: 503-512.
33. Papadopoulos SM, Selden NR, Quint DJ, Patel N, Gillespie B, Grube S: Immediate spinal cord decompression for cervical spinal cord injury: Feasibility and outcome. J Trauma 2002; 52: 323-332.
34. Waters RL, Meyer PR Jr, Adkins RH, Felton D: Emergency, acute, and surgical management of spine trauma. Arch Phys Med Rehabil 1999; 80: 1383-1390.
35. Tator CH, Fehlings MG, Thorpe K, Taylor W: Current use and timing of spinal surgery for management of acute spinal cord injury in North America: Results of a retrospective multicenter study. J Neurosurg 1999; 91(1 suppl): 12-18.
36. Mirza SK, Krengel WF IH, Chapman JR, et al: Early versus delayed surgery for acute cervical spinal cord injury. Clin Orthop Relat Res 1999; 359: 104-114.
37. Ng WP, Fehlings MG, Cuddy B, et al: Surgical treatment of acute spinal cord injury pilot study #2: Evaluation of protocol for decompressive surgery within 8 hours of injury. Neurosurg Focus 1999; 6: e3.
38. Chen TY, Dickman CA, Eleraky M, Sonntag VK: The role of decompression for acute incomplete cervical spinal cord injury in cervical spondylosis. Spine (Phila Pa 1976) 1998; 23: 2398-2403.
39. Vale FL, Burns J, Jackson AB, Hadley MN: Combined medical and surgical treatment after acute spinal cord injury: Results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management. J Neurosurg 1997; 87: 239-246.
40. Waters RL, Adkins RH, Yakura JS, Sie I: Effect of surgery on motor recovery following traumatic spinal cord injury. Spinal Cord 1996; 34: 188-192.
41. Petitjean ME, Mousselard H, Pointillart V, Lassie P, Senegas J, Dabadie P: Thoracic spinal trauma and associated injuries: Should early spinal decompression be considered? J Trauma 1995; 39: 368-372.
42. Bracken MB, Shepard MJ, Hellenbrand KG, et al: Methylprednisolone and neurological function 1 year after spinal cord injury: Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985; 63: 704-713.
43. Bracken MB, Shepard MJ, Collins WF Jr, et al: Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992; 76: 23-31.
44. Bracken MB, Shepard MJ, Holford TR, et al: Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706.
45. Bracken MB, Holford TR: Neurological and functional status 1 year after acute spinal cord injury: Estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. J Neurosurg 2002; 96(3 suppl): 259-266.
46. Eck JC, Nachtigall D, Humphreys SC, Hodges SD: Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine (Phila Pa 1976) 2006; 31: E250-253.
47. Long JB, Martinez-Arizala A, Petras JM, Holaday JW: Endogenous opioids in spinal cord injury: A critical evaluation. Cent Nerv Syst Trauma 1986; 3: 295-315.
48. Chinnock P, Roberts I: Gangliosides for acute spinal cord injury. Cochrane Database Syst Rev 2005; 2: CD004444.
49. Ono H, Nagano N, Yamada M, Fukuda H: Effects of a new analog of thyrotropin-releasing hormone, N alpha[(S)-4-oxo-2-azetidinyl) carbonyl]-L-histidyl-L-prolinamide dehydrate (YM14673) on spinal reflex potentials and flexor reflexes in spinalized rats. Neuropharmacology 1990; 29: 69-74.
50. Leist M, Ghezzi P, Grass G, et al: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004; 305: 239-242.
51. Ehrenreich H, Aust C, Krampe H, et al: Erythropoietin: Novel approaches to neuroprotection in human brain disease. Metab Brain Dis 2004; 19: 195-206.
52. Dinh P, Bhatia N, Rasouli A, Suryadevara S, Cahill K, Gupta R: Transplantation of preconditioned Schwann cells following hemisection spinal cord injury. Spine (Phila Pa 1976) 2007; 32: 943-949.
53. Ramón-Cueto A, Plant GW, Avila J, Bunge MB: Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 1998; 18: 3803-3815.
54. Keirstead HS, Morgan SV, Wilby MJ, Fawcett JW: Enhanced axonal regeneration following combined demyelination plus Schwann cell transplantation therapy in the injured adult spinal cord. Exp Neurol 1999; 159: 225-236.
55. Golden KL, Pearse DD, Blits B, et al: Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol 2007; 207: 203-217.
56. Rasouli A, Bhatia N, Suryadevara S, Cahill K, Gupta R: Transplantation of preconditioned Schwann cells in peripheral nerve grafts after contusion in the adult spinal cord: Improvement of recovery in a rat model. J Bone Joint Surg Am 2006; 88: 2400-2410.
57. Gupta R, Rummler LS, Palispis W, et al: Local down-regulation of myelinassociated glycoprotein permits axonal sprouting with chronic nerve compression injury. Exp Neurol 2006; 200: 418-429.
58. Gupta R, Truong L, Bear D, Chafik D, Modafferi E, Hung CT: Shear stress alters the expression of myelin-associated glycoprotein (MAG) and myelin basic protein (MBP) in Schwann cells. J Orthop Res 2005; 23: 1232-1239.
59. Raisman G, Li Y: Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci 2007; 8: 312-319.
60. Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, Pearse DD: Combining Schwann cell bridges and olfactoryensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 2005; 25: 1169-1178.
61. Huang H, Chen L, Wang H, et al: Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl) 2003; 116: 1488-1491.
62. Perry VH, Brown MC, Gordon S: The macrophage response to central and peripheral nerve injury: A possible role for macrophages in regeneration. J Exp Med 1987; 165: 1218-1223.
63. Schwartz M, Yoles E: Macrophages and dendritic cells treatment of spinal cord injury: From the bench to the clinic. Acta Neurochir Suppl 2005; 93: 147-150.
64. Bomstein Y, Marder JB, Vitner K, et al: Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol 2003; 142: 10-16.
65. Knoller N, Auerbach G, Fulga V, et al: Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine 2005; 3: 173-181.
66. Courts M, Keirstead HS: Stem cells for the treatment of spinal cord injury. Exp Neurol 2008; 209: 368-377.
67. Enzmann GU, Benton RL, Talbott JF, Cao Q, Whittemore SR: Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma 2006; 23: 479-495.
68. Bush G: Executive Order 13435: Expanding approved stem cell lines in ethically responsible ways. Fed Regist 2007; 72: 34591-34592.
69. Akiyama Y, Radtke C, Honmou O, Kocsis JD: Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 2002; 39: 229-236.
70. Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD: Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia 2001; 35: 26-34.
71. Koda M, Okada S, Nakayama T, et al: Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreport 2005; 16: 1763-1767.
72. Yoon SH, Shim YS, Park YH, et al: Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophagecolony stimulation factor: Phase I/II clinical trial. Stem Cells 2007; 25: 2066-2073.
73. Obama B: Executive Order 13505: Removing barriers to responsible scientific research involving human stem cells. Fed Regist 2009; 74: 10667-10668.